ARRAY BIOPHARMA INC's ticker is and the CUSIP is 04269XAA3. A total of 19 filers reported holding ARRAY BIOPHARMA INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $31,917,000 | -49.0% | 22,385,000 | -50.3% | 1.23% | -52.2% |
| Q4 2016 | $62,545,000 | +17.4% | 45,000,000 | 0.0% | 2.57% | +3.9% |
| Q3 2016 | $53,278,000 | +40.9% | 45,000,000 | 0.0% | 2.48% | +66.8% |
| Q2 2016 | $37,815,000 | +5.4% | 45,000,000 | 0.0% | 1.49% | -2.7% |
| Q1 2016 | $35,876,000 | -15.2% | 45,000,000 | 0.0% | 1.53% | -10.9% |
| Q4 2015 | $42,292,000 | -3.6% | 45,000,000 | 0.0% | 1.71% | +1.0% |
| Q3 2015 | $43,864,000 | -23.0% | 45,000,000 | 0.0% | 1.70% | -10.5% |
| Q2 2015 | $56,942,000 | +1.6% | 45,000,000 | 0.0% | 1.90% | +4.5% |
| Q1 2015 | $56,037,000 | +34.7% | 45,000,000 | 0.0% | 1.82% | +21.4% |
| Q4 2014 | $41,604,000 | +39.1% | 45,000,000 | +32.4% | 1.50% | +37.0% |
| Q3 2014 | $29,918,000 | +0.8% | 34,000,000 | +15.3% | 1.09% | -8.5% |
| Q2 2014 | $29,666,000 | +11.3% | 29,500,000 | +13.5% | 1.19% | +9.6% |
| Q1 2014 | $26,665,000 | +11.2% | 26,000,000 | +13.0% | 1.09% | -12.3% |
| Q4 2013 | $23,978,000 | -9.1% | 23,000,000 | 0.0% | 1.24% | +1.2% |
| Q3 2013 | $26,380,000 | +21.1% | 23,000,000 | 0.0% | 1.23% | +19.6% |
| Q2 2013 | $21,778,000 | – | 23,000,000 | – | 1.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TENOR CAPITAL MANAGEMENT Co., L.P. | 16,800,000 | $22,837,000 | 2.09% |
| Redmile Group, LLC | 19,000,000 | $25,656,000 | 1.56% |
| CSS LLC/IL | 17,405,000 | $23,518,000 | 1.14% |
| LINDEN ADVISORS LP | 16,335,000 | $22,249,000 | 0.94% |
| WOLVERINE ASSET MANAGEMENT LLC | 20,715,000 | $28,081,000 | 0.36% |
| Fernwood Investment Management, LLC | 90,000 | $122,000 | 0.09% |
| Baker Brothers Advisors | 3,000,000 | $4,066,000 | 0.04% |
| LAZARD ASSET MANAGEMENT LLC | 13,500,000 | $18,385,000 | 0.04% |
| Citadel Advisors | 22,070,000 | $29,896,000 | 0.02% |
| GABELLI FUNDS LLC | 1,501,000 | $2,037,000 | 0.01% |